SCHEMBL1401382

SCHEMBL1401382

C#Cc1ccc2nc[nH]c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKCI P41743 1/20 0.53
▸ KDM4E B2RXH2 4/20 0.52
▸ MAPT P10636 3/20 0.52
▸ RAD52 P43351 1/20 0.52
▸ MMP12 P39900 1/20 0.49
▸ CYP3A4 P08684 1/20 0.47
▸ NAMPT P43490 1/20 0.47
▸ XDH P47989 1/20 0.47
▸ TDP1 Q9NUW8 2/20 0.46
▸ PKM P14618 1/20 0.46
▸ HDAC6 Q9UBN7 1/20 0.44
▸ HSD11B1 P28845 1/20 0.43
▸ QPCT Q16769 6/20 0.42
▸ QPCTL Q9NXS2 4/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ HPGD P15428 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ ADRA2A P08913 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1401379 0.85 MAPT (0.42) PRKCIKDM4EMAPTRAD52MMP12
SCHEMBL11134 0.81 PRKCI (0.53) PRKCIKDM4EMAPTRAD52MMP12
SCHEMBL4756898 0.81 PRKCI (0.53) PRKCIKDM4EMAPTRAD52MMP12
Hydrochloric Acid SCHEMBL3671411 0.79 KDM4E (0.55) PRKCIKDM4EMAPTRAD52MMP12
SCHEMBL31546841 0.75 MMP12 (0.47) PRKCIKDM4EMAPTRAD52MMP12
SCHEMBL31546813 0.75 MMP12 (0.47) PRKCIKDM4EMAPTRAD52MMP12
SCHEMBL422512 0.74 PRKCI (0.59) PRKCIKDM4EMAPTRAD52MMP12
SCHEMBL11657970 0.73 KDM4E (0.50) PRKCIKDM4EMAPTRAD52MMP12
SCHEMBL8634290 0.73 QPCT (0.68) PRKCIKDM4EMAPTRAD52MMP12
SCHEMBL31619933 0.72 PRKCI (0.57) PRKCIKDM4EMAPTRAD52MMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025076285-A1 COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME DELPHIA THERAPEUTICS, INC. (US) 2025-04-10 — — WO disclosed
EP-1383761-B1 Phenyl- and pyridyl-piperidines with tnf activity SANOFI AVENTIS (FR) 2011-03-02 — — EP disclosed
EP-1383762-B1 TETRAHYDROPYRIDYL-ALKYL-HETEROCYCLES, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SANOFI AVENTIS (FR) 2007-06-20 — — EP disclosed
EP-1383761-A1 PHENYL- AND PYRIDYL-PIPERIDINES WITH TNF ACTIVITY Sanofi-Aventis (FR) 2004-01-28 — — EP disclosed
EP-1383762-A1 TETRAHYDROPYRIDYL-ALKYL-HETEROCYCLES, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME Sanofi-Aventis (FR) 2004-01-28 — — EP disclosed
WO-2002085887-A1 PHENYL- AND PYRIDYL-PIPERIDINES WITH TNF ACTIVITY SANOFI-SYNTHELABO (FR) 2002-10-31 — — WO disclosed
WO-2002085888-A1 TETRAHYDROPYRIDYL-ALKYL-HETEROCYCLES, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SANOFI-SYNTHELABO (FR) 2002-10-31 — — WO disclosed
Send feedback